Effects of pelvic microbiome features on female reproductive health

Main Article Content

Zuleikha R. Khasanshina
Natalya V. Bogacheva

Abstract

Among the many causes of female infertility, there are features of the composition of the "normal" microbiome, characterized by: interspecific changes in the ratio of representatives of the genus Lactobacillus; quantitative imbalance of lactobacilli with representatives of other types of microorganisms contained in the vagina and uterus; pelvic inflammatory disease (PID); tendency to form biofilms contributing to the progression of antibiotic resistance, etc. Pelvic organs contain their own typical microbiome, which accounts for 9% of the total bacterial population in women. Among the spectrum of microorganism species, the female sex tract is mostly dominated by Lactobacillus species, which are considered among the most important microorganisms. Although the existence of the vaginal microbiome has long been established, the upper section of the reproductive tract was considered a sterile environment, with the assumption that the presence of bacteria is associated with adverse clinical manifestations. However, modern research has revealed certain patterns of the microbiome colonizing the uterus, endometrium, fallopian tubes, ovaries and placenta. Bacterial colonization of these sites is different from vaginal, despite evidence that vaginal bacteria can ascend into the upper genital tract through the cervix. The review presents systematic scientific evidence on the microbiome of the lower and upper reproductive tract of women. The issues of pelvic microbiome influence on a woman's reproductive health are considered. The feasibility of assessing the state of the pelvic microbiome at all stages of monitoring the health of a woman in the system of gynecological institutions, which can become a useful screening tool for successful reproductive function, is justified.
.

Article Details

How to Cite
Khasanshina З. Р. ., & Bogacheva Н. В. . (2025). Effects of pelvic microbiome features on female reproductive health. Bulletin of Perm University. Biology, (1), 59–68. https://doi.org/10.17072/1994-9952-2025-1-59-68
Section
Микробиология
Author Biographies

Zuleikha R. Khasanshina, Kirov State Medical University, Kirov, Russia

applicant of the Department of Microbiology and Virology

Natalya V. Bogacheva, Kirov State Medical University, Kirov, Russia

doctor of medical sciences, professor at the Department of Microbiology and Virology

References

Брагина Т.В., Петров Ю.А., Палиева Н.В. Воспалительные заболевания органов малого таза как одна из причин женского бесплодия // Пульc. 2021. № 12. С. 77–84. DOI: 10.26787/nydha-2686-6838-2021-23-12-77-84. EDN: PVFXJU.

Бурова А., Жаркин Н.А., Ярыгин О.А. Особенности микробного пейзажа и его антибиотикорези-стентности у женщин с воспалительными заболеваниями органов малого таза в волгоградском регионе // Вестник Волгоградского ГМУ. 2017. Т. 2, № 62. С. 56–58.

Гаранина Е.Е. и др. Инфламмасомы: роль в патогенезе заболеваний и терапевтический потенциал // Ученые записки Казан. ун-та. Сер. Естественные науки. 2020. Т. 162, № 1. С. 80–111. DOI: 10.26907/2542-064X.2020.1.80-111. EDN: CFDRQF.

Гречканев Г.О. Этиопатогенез и современные подходы к лечению бактериального вагиноза (обзор) // Медицинский альманах. 2023. Т. 3, № 76. С. 16–23. EDN: KOGONP.

Ильина Т.С., Романова Ю.М. Бактериальные биопленки: роль в хронических инфекционных про-цессах и поиск средств борьбы с ними // Молекулярная генетика, микробиология и вирусология. 2021. Т. 39, № 2. С. 14–24. DOI: 10.17116/molgen20213902114. EDN: RHLJAM.

Лукьянова Я.М. Биопленки: строение, регуляция и роль в воспалительных процессах // Scientist. 2023. Т. 23, № 1. С. 90–94. EDN: ELEWMT.

Рахматуллаева М., Наврузова Н. Вагинальное полимикробное сообщество: его вклад в развитие бактериального вагиноза // Доктор ахборотномаси. 2021. № 1 (98). С. 151–159.

Турсунова Н.Б. и др. Современный взгляд на роль микробиома женского репродуктивного тракта в исходах ЭКО // Акушерство, гинекология и репродукция. 2023. Т. 17, № 4. С. 512–525. DOI: 10.17749/2313-7347/ob.gyn.rep.2023.433. EDN: SXDKKR.

Шалепо К.В., Михайленко Т.Г., Савичева А.М. Роль бактериальных пленок в формировании хро-нических патологических процессов во влагалище и эндометрии // Журнал акушерства и женских бо-лезней. 2016. Т. 65, № 4. С. 65–75. DOI: 10.17816/JOWD65465-75. EDN: WRKPJV.

Abdou R., Miller T. Postpartum tubo-ovarian abscess, likely arising from pelvic inflammatory disease during pregnancy // Case Reports. 2017. Vol. 2017. P. 201–220. DOI: 10.1136/bcr-2017-220183.

Abou C.L., Fenollar F., Diop K. Bacterial vaginosis: what do we currently know? // Frontiers in cellular and infection microbiology. 2022. Vol. 11. P. 1–13. DOI: 10.3389/fcimb.2021.672429. EDN: XJRDVU.

Anahtar M.N. et al. Cervicovaginal microbiota and reproductive health: the virtue of simplicity // Cell host & microbe. 2018. Vol. 23. P. 159–168. DOI: 10.1016/j.chom.2018.01.013. EDN: YHFDVR.

Balakrishnan S.N. et al. Role of vaginal mucosa, host immunity and microbiota in vulvovaginal candid-iasis // Pathogens. 2022. Vol. 11, № 6. P. 1–15. DOI: 10.3390/pathogens11060618. EDN: TDDDJW.

Bridwell R.E., Koyfman A., Long B. High risk and low prevalence diseases: tubo-ovarian abscess // The American Journal of Emergency Medicine. 2022. Vol. 57. P. 70–75. DOI: 10.1016/j.ajem.2022.04.026. EDN: VEQYRY.

Chayachinda C., Rekhawasin T. Reproductive outcomes of patients being hospitalised with pelvic in-flammatory disease // Journal of Obstetrics and Gynaecology. 2017. Vol. 37. P. 228–232. DOI: 10.1080/01443615.2016.1234439.

Chen K.Y., Tseng J.Y., Yang C.Y. Tubo-ovarian abscess with sepsis in a nonagenarian woman: a case report and literature review // BMC women's health. 2019. Vol. 19. P. 1–4. DOI: 10.1186/s12905-019-0782-6. EDN: WQKICE.

Curry A., Williams T., Penny M. L. Pelvic inflammatory disease: diagnosis, management, and prevention // American family physician. 2019. Vol. 100, №. 6. P. 357–364.

Dave S. et al. Which community-based HIV initiatives are effective in achieving UNAIDS 90-90-90 tar-gets? A systematic review and meta-analysis of evidence (2007-2018) // PLoS One. 2019. Vol. 17, № 14(7). P. 1–18. DOI: 10.1371/journal.pone.0219826.

De Seta F. et al. The vaginal community state types microbiome-immune network as key factor for bac-terial vaginosis and aerobic vaginitis // Fronties in Microbiology. 2019. Vol. 10. P. 483–585. DOI: 10.3389/fmicb.2019.02451.

Denning D.W. et al. Global burden of recurrent vulvovaginal candidiasis: a systematic review // The Lan-cet Infectious Diseases. 2018. Vol. 18. P. 339–347. DOI: 10.1016/S1473-3099(18)30103-8. EDN: WXONRX.

Gholiof M., Adamson-De Luca E., Wessels J.M. The female reproductive tract microbiotas, inflamma-tion, and gynecological conditions // Frontiers in Reproductive Health. 2022. Vol. 4. P. 963–975. DOI: 10.3389/frph.2022.963752. EDN: FYCQEZ.

Jafarzadeh L. et al. Vulvovaginal candidiasis: an overview of mycological, clinical, and immunological aspects // Journal of Obstetrics and Gynaecology Research. 2022. Vol. 48, № 7. P. 1546–1560. DOI: 10.1111/jog.15267. EDN: TQMEDW.

Kalia N., Singh J., Kaur M. Microbiota in vaginal health and pathogenesis of recurrent vulvovaginal in-fections: a critical review // Annals of Clinical Microbiology and Antimicrobials. 2020. Vol. 19, № 1. P. 1–19. DOI: 10.1186/s12941-020-0347-4. EDN: TUWXHA.

Kaur H. et al. Crosstalk between female gonadal hormones and vaginal microbiota across various phas-es of women’s gynecological lifecycle // Frontiers in microbiology. 2020. Vol. 11. P. 1–11. DOI: 10.3389/fmicb.2020.00551. EDN: ULQIFJ.

Koedooder R. et al. The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: a prospective study // Human Reproduction. 2019. Vol. 34. P. 1042–1054. DOI: 10.1093/humrep/dez065.

Kyono K. et al. Analysis of endometrial microbiota by 16S ribosomal RNA gene sequencing among in-fertile patients: a single‐center pilot study // Reproductive Medicine and Biology. 2018. Vol. 17. P. 297–306. DOI: 10.1002/rmb2.12105.

Ma Z.S., Li L. Quantifying the human vaginal community state types (CSTs) with the species specificity index // PeerJ. 2017. Vol. 5. P. 33–66. DOI: 10.7717/peerj.3366.

Maksimovic C. et al. Vaginal dysbiosis – the association with reproductive outcomes in IVF patients: a systematic review and meta-analysis // Current Opinion in Obstetrics and Gynecology. 2024. Vol. 36, № 3. P. 155–164. DOI: 10.1097/gco.0000000000000953. EDN: JNCGKR.

Mitchell C.M. et al. Colonization of the upper genital tract by vaginal bacterial species in nonpregnant women // American Journal of Obstetrics and Gynecology. 2015. Vol. 212. P. 611–619. DOI: 10.1016/j.ajog.2014.11.043.

Mohseni M. et al. Epidemiologic and clinical characteristics of tubo-ovarian abscess, hydrosalpinx, pyosalpinx, and oophoritis in emergency department patients // Cureus. 2020. Vol. 12, № 11. P. 1–11. DOI: 10.7759/cureus.11647. EDN: HOJCVG.

Moreno I., Simon C. Deciphering the effect of reproductive tract microbiota on human reproduction // Reproductive medicine and Biology. 2019. Vol. 18. P. 40–50. DOI: 10.1002/rmb2.12249.

Padmaja N. et al. Role of microbial agents in reproductive health // JK Science: Journal of Medical Edu-cation & Research. 2021. Vol. 23. №. 2. P. 106-110.

Sobel J.D., Vempati Y.S. Bacterial Vaginosis and vulvovaginal candidiasis pathophysiologic interrela-tionship // Microorganisms. 2024. Vol. 12, № 108. P. 1–10. DOI: 10.3390/microorganisms12010108. EDN: GDRKZQ.

Tachedjian G., O’Hanlon D.E., Ravel J. The implausible «in vivo» role of hydrogen peroxide as an anti-microbial factor produced by vaginal microbiota // Microbiome. 2018. Vol. 6. P. 1–5. DOI: 10.1186/s40168-018-0418-3. EDN: UASBXU.

To V., Gurberg J., Krishnamurthy S. Tubo-ovarian abscess caused by Candida albicans in an obese pa-tient // Journal of Obstetrics and Gynaecology Canada. 2015. Vol. 37. P. 426–429. DOI: 10.1016/S1701-2163(15)30257-7.

Waetjen L., et al. Relationships between the vaginal microbiota and genitourinary syndrome of meno-pause symptoms in postmenopausal women: the Study of Women's Health Across the Nation // Menopause. 2023. Vol. 30, № 11. P. 1073–1084. DOI: 10.1097/gme.0000000000002263. EDN: AKEXDK.

Waikhom S.D. et al. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho munici-pality, Ghana: species identification and antifungal susceptibility of Candida isolates // BMC Pregnancy Child-birth. 2020. Vol. 20, № 1. P. 2–14.

Wang N. et al. The effects of microbiota on reproductive health: a review // Critical Reviews in Food Sci-ence and Nutrition. 2024. Vol. 64, № 6. P. 1486–1507. DOI: 10.1080/10408398.2022.2117784.

Willems H.M.E. et al. Vulvovaginal candidiasis: a current understanding and burning questions // Journal of Fungi (Basel). 2020. Vol. 25, № 6. P. 1–20. DOI: 10.3390/jof6010027. EDN: LRETVX.